Note 9 - Segment Information and Disaggregated Revenue

6 Months Ended

Dec. 31, 2021

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note 9. Segment Information and Disaggregated Revenue

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into two reportable segments as follows: Contract Manufacturing, and Other Nutraceutical Businesses. International sales, concentrated primarily in Europe, for the three months ended December 31, 2021 and 2020 were $2,333 and $1,750, respectively and for the six months ended December 31, 2021 and 2020 were $4,553 and $3,217, respectively.

Financial information relating to the three months ended December 31, 2021 and 2020 operations by business segment and disaggregated revenues was as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract Manufacturing	2021	$	11,729	$	2,333	$	14,062	$	1,550	$	78	$	177
	2020		12,168		1,704		13,872		2,069		86		64
Other Nutraceutical Businesses	2021		532		-		532		200		1		-
	2020		339		46		385		105		1		-
Total Company	2021		12,261		2,333		14,594		1,750		79		177
	2020		12,507		1,750		14,257		2,174		87		64

Financial information relating to the six months ended December 31, 2021 and 2020 operations by business segment and disaggregated revenues was as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract Manufacturing	2021	$	21,874	$	4,523	$	26,397	$	2,851	$	162	$	308
	2020		25,492		3,166		28,658		4,325		168		114
Other Nutraceutical Businesses	2021		918		30		948		323		2		-
	2020		720		51		771		222		2		3
Total Company	2021		22,792		4,553		27,345		3,174		164		308
	2020		26,212		3,217		29,429		4,547		170		117

	Total Assets as of
	December 31,		June 30,
	2021		2021
Contract Manufacturing	$	22,183	$	21,333
Other Nutraceutical Businesses		4,888		4,107
Total Company	$	27,071	$	25,440